Resecurity Unveils AI-Driven Compliance Manager at ISACA 2025 North America Conference

LOS ANGELES--(BUSINESS WIRE)-- Resecurity, a leading U.S.-based cybersecurity and threat intelligence company, has officially launched its AI-driven Compliance Manager at ISACA 2025 North America Conference in Orlando, Florida. The cutting-edge solution is engineered to help CISOs and compliance teams manage complex regulatory demands, reduce risk, and maintain alignment with fast-changing global cybersecurity standards.
The Compliance Manager delivers centralized visibility, automation, and expert-level guidance to ensure organizations stay audit-ready and resilient in the face of expanding data protection and information security regulations. The platform currently supports over 20 international and regional compliance frameworks, including:
GDPR (General Data Protection Regulation - EU)
SAMA (Saudi Arabian Monetary Authority)
DORA (Digital Operational Resilience Act – EU)
PDPL (Saudi Arabia)
DPDPA (India)
DPA (Philippines)
CMMC (Cybersecurity Maturity Model Certification – U.S. DoD)
NIS2 Directive (EU)
RBI Cybersecurity Guidelines (Reserve Bank of India)
PCI DSS v4.0.1
ISO/IEC 27001
NCA ECC (National Cybersecurity Authority's Essential Cybersecurity Controls – Saudi Arabia)
To address increasing pressure from regulators and threats, Resecurity's solution introduces a 'human-in-the-loop' AI architecture. This empowers cybersecurity leaders with GenAI-driven insights and adaptive compliance recommendations, tailored to evolving standards. The system maps controls, evaluates risk exposure, and enables real-time compliance monitoring — reducing manual workload and audit preparation time.
'Regulatory landscapes are evolving faster than ever, and the cost of non-compliance can reach millions in penalties — not to mention reputational damage,' said Gene Yoo, CEO of Resecurity. 'With our Compliance Manager, we're arming CISOs with a smart, scalable assistant that not only monitors compliance but actively helps close gaps in real time.'
In some regions, penalties for non-compliance can exceed $10 million, or amount to 2–4% of annual global revenue, placing tremendous pressure on organizations to maintain continuous compliance.
The Compliance Manager is fully integrated into the Resecurity platform, enabling unified threat, risk, and compliance (GRC) management under a single pane of glass.
About Resecurity
Resecurity® is a cybersecurity company that delivers a unified endpoint protection, fraud prevention, risk management, and cyber threat intelligence platform. Known for providing best-of-breed data-driven intelligence solutions, Resecurity's services and platforms focus on early-warning identification of data breaches and comprehensive protection against cybersecurity risks. Founded in 2016, it has been globally recognized as one of the world's most innovative cybersecurity companies with the sole mission of enabling organizations to combat cyber threats regardless of how sophisticated they are. Most recently, by Inc. Magazine, Resecurity was named one of the Top 10 fastest-growing private cybersecurity companies in Los Angeles, California. As a member of InfraGard National Members Alliance (INMA), AFCEA, NDIA, SIA, FS-ISAC, and the American Chamber of Commerce in Saudi Arabia (AmChamKSA), Singapore (AmChamSG), Korea (AmChamKorea), Mexico (AmChamMX), Thailand (AmChamThailand), and UAE (AmChamDubai). To learn more about Resecurity, visit https://resecurity.com.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Hamilton Spectator

an hour ago

• Hamilton Spectator

Canada-Europe security and defence pact to be signed Monday in Brussels

OTTAWA - A security and defence partnership pact Prime Minister Mark Carney will sign with European leaders in Brussels on Monday will be among the most wide-ranging agreements with a third country Europe has ever reached, a senior EU official said on Friday. Carney is flying to Europe Sunday for a Canada — EU Summit, planned for Monday evening with European Council President António Costa and European Commission President Ursula von der Leyen. At the G7 summit in Alberta on Monday von der Leyen confirmed that the agreement will be signed on Monday in Brussels, calling Canada a 'key partner.' 'This is also a moment where we can strengthen Canada's role in Europe's rapidly evolving defence architecture,' said Von der Leyen on June 16. In a briefing to Canadian and European reporters on Friday, a senior European official said there will be two main outcomes from the summit — a joint statement that expresses views on global issues, such as conflicts in Ukraine and the Middle East, as well as the signing of the 'EU Canada Security and Defence Partnership Agreement.' 'This is an ambitious one,' the official said. 'And actually we've had this with a number of global partners, but the one with Canada would be one of the most far reaching of its kind that the EU has ever signed with a third country. It will open up new avenues for joint work on crisis management, military mobility, maritime security, cyber and cyber threats, and defence industrial co-operation.' Carney has been clear that he intends to expand Canada's ties with Europe as its relationship with the United States strains under the weight of tariffs and threats of annexation. Within two days of being sworn in as prime minister in March Carney flew to Europe, meeting with French President Emmanuel Macron in Paris and British Prime Minister Keir Starmer in London. It was during those meetings that he seriously began talking about signing on to Europe's new defence procurement plan known as ReArm Europe. In the throne speech on May 27, Carney's government pledged to join that program, and he told the CBC in an interview that same day he expected Canada to do that by July 1. On June 9, Carney announced a massive investment in Canada's defence budget to push Canada above the two per cent of GDP NATO target this country has promised — and failed — to meet for more than a decade. Joining ReArm Europe is part of that plan, with Carney repeatedly saying Canada can no longer put all its defence spending into the U.S. 'We are in close discussions with our European partners to join ReArm Europe,' he said on June 9. 'That will be an element of diversification. That's just smart. It's better to be diversified. It's better to have options. It's better to have different supply chains and broader partners.' The agenda for the summit posted by the European Council says the security and defence procurement agreement will allow Canada to join a European loan program for joint defence projects. That 150-billion euro program — called Security Action for Europe, or SAFE — is part of the ReArm Europe initiative. The EU official said on Friday that once the procurement agreement is in place, Canada will have to negotiate a bilateral agreement with the European Commission to begin discussions with member states about procurement opportunities. Leaders at the EU-Canada summit are also expected to discuss global trade and the wars raging in Ukraine and the Middle East. They will also commit to fully ratifying the Comprehensive Economic and Trade Agreement, the Canada-Europe free trade agreement known as CETA. Fen Hampson, a professor of international affairs at Carleton University, said Carney also should put the 'pedal to the metal' on ratifying CETA. The deal entered into force provisionally in 2017, but several EU member states still need to ratify CETA at the national level. 'The real challenge there is to get Canadian businesses and also European businesses to take it up … and to start doing more business across the Atlantic, but that also requires political leadership,' Hampson said. 'It hasn't been fully ratified but that's something (Carney) can perhaps impress upon the Europeans.' After Brussels, Carney will travel to The Hague for the NATO leaders' summit, where discussions are expected to push forward on increasing the NATO members' defence spending target as high as five per cent of GDP, from the current two per cent. — With files from Kyle Duggan, Dylan Robertson and The Associated Press This report by The Canadian Press was first published June 20, 2025. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .

Forbes

4 hours ago

• Forbes

Leadership Falters As Climate Costs Soar And Time To Act Runs Out

CHARLEVOIX, CANADA - JUNE 9: In this photo provided by the German Government Press Office (BPA), ... More German Chancellor Angela Merkel deliberates with US president Donald Trump on the sidelines of the official agenda on the second day of the G7 summit on June 9, 2018 in Charlevoix, Canada. Also pictured are (L-R) Larry Kudlow, director of the US National Economic Council, Theresa May, UK prime minister, Emmanuel Macron, French president, Angela Merkel, Yasutoshi Nishimura, Japanese deputy chief cabinet secretary, Shinzo Abe, Japan prime minister, Kazuyuki Yamazaki, Japanese senior deputy minister for foreign affairs, John Bolton, US national security adviser, and Donald Trump. Canada are hosting the leaders of the UK, Italy, the US, France, Germany and Japan for the two day summit. (Photo by Jesco Denzel /Bundesregierung via Getty Images) London Climate Action Week is set to start, showcasing what urgent, inclusive climate action looks like when cities, financiers, and citizens unite. But the energy and innovation on display in London are being overshadowed by growing inaction from global leaders. Just days after the G7 failed to deliver any meaningful policy progress, and as the EU backpedals on its green regulation agenda, a troubling gap is emerging between local ambition and failures of international leadership. This retreat is happening at the worst possible moment. Climate damage costs are skyrocketing, climate science is sounding red alerts, and economic evidence points to a clear win: green investment can grow economies, create jobs, and protect communities. The world's most powerful leaders are not just missing an opportunity, they are magnifying a crisis. To grasp its scale, we need to look at the growing economic cost of inaction. The Price Of Delay And The Need For Leadership Bloomberg Intelligence has estimated that in the year to May 2025, the U.S. incurred close to $1 trillion (or around 3% of GDP) in direct climate-related costs from floods, wildfires, infrastructure damage, and insurance losses. Globally, heatwaves, droughts, and extreme weather are disrupting supply chains, inflating food prices, and undermining financial stability. Insurers have seen annual catastrophe losses surge tenfold since the 1980s. Premiums have skyrocketed, and coverage has shrunk, especially in wildfire and storm prone regions, exacerbating economic disruption and housing unaffordability. At the same time, the European Union appears to be shelving the Green Claims Directive, retreating under political pressure precisely when markets are demanding clear, consistent regulation to guide sustainable investment. This uncertainty discourages capital and undermines momentum. These setbacks comes as the OECD's 2025 Green Growth report shows that climate action could unlock $7.4 trillion per year in investment and job creation if scaled by 2030. Yet rather than harnessing this opportunity, many leaders are hesitating. Nowhere is this hesitancy more evident than in the recent action, or inaction, of the G7, whose decisions ripple far beyond their border G7 Paralysis And The Global Ripple Effect The G7's latest Chair's Summary reaffirms familiar goals, like limiting warming to 1.5°C but offered no timelines, targets, or tools to achieve it. 'Once again, the G7 chose safe, business-as-usual declarations over the bold, future-proof action we urgently need,' said Daniela Fernandez, CEO of Sustainable Ocean Alliance. 'The G7's latest climate commitments reflect a deeper issue,' added Ibrahim AlHusseini, managing partner of climate investor FullCycle. 'Global leaders are increasingly distracted by immediate geopolitical crises, and climate, still perceived as a medium to long-term risk, has slipped down the agenda. But this is a dangerous miscalculation.' He added: 'Delay is not neutral, it's an accelerant of future instability,' with direct consequences for supply chains, migration, and global financial systems. And it's not just experts calling for change. According to the 2024 People's Climate Vote, 80% of people globally want their countries to strengthen climate commitments, and over two-thirds support a fast transition from fossil fuels. Other surveys echoes this: 89% of people across 125 countries support stronger government action, yet many mistakenly believe they are in the minority. This public mandate for bold climate action stands in sharp contrast to the political hesitancy now on display. As political will may be stalling, another sector is responding. What was once viewed as an environmental issue is now a pressing financial risk. Climate Risk Becomes Financial Risk Inaction is not just costly, it is destabilizing. The financial consequences are already unfolding across insurance markets and beyond. "We have already seen residential and commercial insurance premiums rise and availability drop in recent years, in response to growing insurer losses," warns Tom Sabetelli-Goodyer, vice-president of climate risk at FIS. They are early signs of a broader, systemic threat. As climate impacts intensify, they are cascading through the financial system, affecting asset valuations, credit risk, and the stability of entire markets. Regulators around the world have begun to integrate climate risk into their frameworks, but last week, the Basel Committee on Banking Supervision, the global standard-setter for financial regulation, added its voice with a new framework for the voluntary disclosure of climate-related financial risks. While non-binding, the guidance marks a significant step and reinforces a clear message: climate risk is no longer just environmental, it's financial. As Julia Symon, head of research and advocacy at Finance Watch put it: 'Without clear, consistent data, supervisors are flying blind, unaware of the real risks building up on balance sheets.' The Climate Clock Is Ticking Scientific indicators confirm the urgency and the danger of delay. The 2024 Indicators of Global Climate Change report shows that the average global temperature from 2015 to 2024 reached 1.24°C above pre-industrial levels, with human activity responsible for nearly all of it. In 2024 alone, global temperatures spiked to 1.52°C, temporarily crossing the critical 1.5°C threshold. More troubling still, human-induced warming is accelerating at an unprecedented rate of 0.27°C per decade, the fastest rate ever recorded. At current emissions levels, the remaining carbon budget for staying below 1.5°C could be fully exhausted within just two to five years, depending on assumptions. Scientists also point to a growing Earth energy imbalance and early signs of amplifying climate feedback loops, such as ocean heat uptake and ice melt, which could further lock in extreme changes. The window for keeping global heating within safe limits is narrowing quickly. Yet even as time runs short, the economic case for prompt action continues to strengthen. Green growth offers a rare convergence of climate responsibility and financial return. Green Growth: A Trillion-Dollar Opportunity The OECD Green Growth report emphasizes that investing in clean energy and green infrastructure is not just responsible, its smart economics. Clean energy investment now outpaces fossil fuels, and 90% of global GDP is covered by net-zero targets. The report outlines how aligning financial systems with climate goals could unlock $7.4 trillion annually in investment by 2030. 'Green growth is an approach that seeks to harmonize economic growth with environmental sustainability and helps to deliver broader development benefits,' explains Jennifer Baumwoll, head of climate strategies and policy at UNDP. Far from hindering development, the green transition can generate resilient jobs, improve productivity, and enhance long-term competitiveness. In short, the report argues that climate action is not a cost but a catalyst for growth. Countries like Mongolia and Lao PDR are already demonstrating what this looks like in practice. In Mongolia, a green finance strategy, backed by the Central Bank and a new SDG-aligned taxonomy, has mobilized $120 million in climate-aligned investment, including the country's first green bond. Green lending is targeted to grow from 2% to 10% of all bank lending by 2030. Meanwhile, Lao PDR is advancing a national circular economy roadmap to reduce waste and resource use while unlocking economic opportunity. If fully implemented, it could create 1.6 million jobs and add $16 billion to GDP by 2050. These pragmatic, investment-ready models of climate action deliver real development gains. Their progress underscores a growing global divide: while emerging economies embrace opportunity, many developed nations are falling behind, precisely when their leadership is most needed. A Shrinking Window And Defining Test Of Leadership 2025 marks a critical juncture. Countries are expected to submit new national climate plans (NDCs 3.0) ahead of COP30 in Belém this November. Yet as of late June 2025, four months after the February deadline, only a small fraction had done so. Intended to reflect increased ambition following the Global Stocktake, most submissions remain overdue, and the ambition gap continues to widen. The UN expects a surge of last-minute filings, but tardiness isn't the only concern. Most existing plans fall short of aligning with the 1.5°C target, and the policy frameworks to deliver them at scale are still lacking. The challenge is not technical though but political. Instead of advancing, many major economies are retreating, weakening targets, delaying regulations, and rolling back commitments just as the case for bold action becomes stronger. Evidence shows that a well-managed transition can boost growth, reduce inequality, and build resilience. Yet that potential is being squandered. What's needed now is not just political courage, but real leadership, capable of driving structural reform and aligning finance with planetary boundaries. Decisive action today isn't only about avoiding catastrophe, it's about exercising leadership that can shape a more stable, equitable, and liveable world. The responsibility lies with those in power to act—not later, but now.

Business Wire

7 hours ago

• Business Wire

GE HealthCare drives innovation in theranostics with latest technological advances

CHICAGO--(BUSINESS WIRE)--At this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare's MIM Software introduces LesionID Pro with automated zero-click pre-processing i – an AI-powered innovation to help aid physician decision making and therapy response monitoring. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief Share With cancer accounting for over 10 million deaths globally each year, ii the rise of precision care – particularly theranostics – is offering new hope to patients. By combining advanced diagnostic imaging and radiopharmaceuticals with targeted therapies, theranostics enables a personalized, patient-centric approach that may help improve disease detection, treatment accuracy, and overall quality of life. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief of Nuclear Medicine, Associate Clinical Professor, Department of Radiological Sciences, University of California, Irvine. 'With tools like GE HealthCare's Omni Legend, StarGuide, and MIM software at our disposal, we now have the ability to visualize disease with great clarity, quantify tumor burden efficiently, and make fast, informed decisions. These advancements are not only helping enhance diagnostic accuracy and therapy monitoring but are also opening the door to dosimetry—ultimately helping improve outcomes for our patients. This is precision care in action, and it's making a real difference in patients' lives.' Central to the practice of theranostics is molecular imaging, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), which provides detailed, patient-specific insights to guide and monitor treatment. However, accessing these insights – like whole-body tumor burden, which represents the total amount of cancer is in the body – has traditionally required time-consuming manual analysis, resulting in clinical and operational challenges. In response, GE HealthCare's MIM Software is introducing LesionID Pro with automated zero-click pre-processing, i designed with AI-powered automation to help physicians access reliable whole-body tumor burden statistics without having to spend hours manually segmenting lesions, removing normal physiologic uptake, and registering multiple patient images for comparison. In addition to turning manual pre-processing into a zero-click experience, this new version of LesionID Pro comes with significant algorithm improvements that provide physicians with a precise whole-body tumor volume to review and finalize. Intuitive, user-friendly tools were intentionally designed with input from leading theranostics practitioners with the ultimate goal of making whole-body tumor burden analysis a practical clinical reality and help shorten physicians' time-to-report. 'At GE HealthCare, we are dedicated to providing clinicians the precision care tools needed for the adoption and practice of theranostics,' shares Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE HealthCare. 'We designed our portfolio of precision care solutions to evolve with healthcare system needs and help support a patient's entire care journey – from the imaging equipment needed for a noninvasive look at a patient's anatomy and treatment monitoring, to novel radiopharmaceuticals used to diagnose and monitor disease and the systems required to produce them, to the software optimized to enable data-driven decision-making. In the hands of clinicians, these tools help advance the global practice of personalized medicine and help improve patient outcomes.' Also on display at #SNMMI25, as part of GE HealthCare's comprehensive portfolio of theranostics-enabling solutions for clinical and operational excellence, are the following innovations: MINItrace Magni, iii GE HealthCare's newest cyclotron technology, designed with a small footprint (about the size of a commercial refrigerator) and the goal of providing an easy-to-site, easy-to-install solution for the reliable, in-house production of commercial PET tracers and radiometals, including Gallium-68, used in diagnostic imaging to support personalized care plans. Adoption of such easy-to-site, easy-to-install technology may help enhance the capabilities of the healthcare system but also grant clinicians the ability to offer a variety of tracers to their patients and encourage the practice of precision care locally, helping fuel inhouse Theranostics capabilities. Omni Legend is a performance-focused PET/CT designed to evolve and help meet growing healthcare system demands by enabling clinicians to reduce dose by up to 40% iv while maintaining exceptional image quality. Supportive of the diagnostic portion of theranostics, the system continues to gain in popularity, representing the company's fastest-ever-selling PET/CT. v StarGuide is a digital SPECT/CT with a 12 CZT detector design that delivers high-quality 3D images and short scan times. Optimized for certain theranostic procedures, the system is designed to help clinicians pinpoint the size, shape, and position of lesions and monitor therapy with exceptional precision. Its flexibility in patient scanning and workflow efficiencies also support high patient throughput and help reduce complexity. For oncology patients, especially those in pain, short scans can help enhance comfort and overall experience. Aurora is an advanced dual-head SPECT/CT designed with excellent diagnostic capabilities vi and streamline workflows, offering clinicians excellent image quality and operational efficiency. Its CT has a 40 mm detector – twice the detector coverage compared to CTs of other hybrid systems vii – with the ability to reduce the dose up to 82%, viii support accurate quantitation, and help clinicians make the personalized care decisions that are at the heart of theranostics. Theranostics Pathway Manager Tile is an easy-to-use application, available on GE HealthCare's Command Center software, that is designed to simplify the time-consuming task of coordinating the theranostics care pathway. It does so by tracking patient readiness for therapy, eliminating the need for manual data gathering across disparate systems (e.g., labs, scheduling, ordering, spreadsheets), and providing a unified, up-to-date view of each patient's treatment journey. Oregon Health & Science University will be an early adopter. 'Every day counts when it comes to cancer care. The latest theranostics solutions will help our care teams more quickly and easily keep tabs on patient readiness and reduce patient coordination time—freeing up more time for clinicians to focus on direct patient care,' says Erik Mittra, M.D., Ph.D., professor of diagnostic radiology in the at Oregon Health & Science University. Altogether, GE HealthCare has the unique ability to provide solutions along every step of the theranostics care pathway. Our integrated portfolio of solutions provides clinicians with the isotopes, imaging, informatics, and molecular imaging agents necessary for the practice and advancement of precision care. For more information on GE HealthCare's innovative portfolio of theranostics-enabling solutions, please visit SNMMI show attendees are also encouraged stop by the company's booth (#638 and #1023) at New Orleans Ernest N. Morial Convention Center in New Orleans, Louisiana from June 21-24. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™. Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website for more information. i LesionID Pro with automated zero-click pre-processing is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region. ii Cancer. World Health Organization. Published February 3, 2022. Accessed March 2, 2023. iii Technology in development that represents ongoing research and development efforts. These technologies are not products and may never become products. Not CE marked. iv Omni Legend 21cm as compared to Discovery MI Gen1 20cm. As demonstrated in phantom testing. v Based on orders data of GE HealthCare PET/CT systems since 2010. vi Compared to NM/CT 870 DR. vii As compared to NM/CT 870 DR with Optima 540 CT. viii a ASiR-V reduces dose by 50% to 82% relative to FBP at the same image quality (Image quality as defined by low contrast detectability). viii b In clinical practice, the use of ASiR‐V may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Low Contrast Detectability (LCD), Image Noise, Spatial Resolution and Artifact were assessed using reference factory protocols comparing ASiR‐V and FBP. The LCD was measured using 0.625 mm slices and tested for both head and body modes using the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using a model observer method.